China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026)
China Pharma Holdings (CPHI) posted Exchange Rate Effect of -$42021.0 for Q1 2026, down 1189.76% on a QoQ basis from $3856.0 in Q4 2025, and down 682.37% year-over-year from $7215.5 in Q1 2025.
China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026) Analysis & Trends
China Pharma Holdings' Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$42021.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 682.37% year-over-year to -$42021.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35400.0 (up 44.78% YoY) and the FY2025 annual result came in at $1250.0, up 101.91% from the prior year.
- Exchange Rate Effect was -$42021.0 for Q1 2026 at China Pharma Holdings, down from $3856.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $50439.0 in Q4 2023 and bottomed at -$153626.0 in Q3 2022.
- A 5-year average of -$18930.3 and a median of -$5371.0 in 2025 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 1283.72% in 2022, while the deepest fall reached 3654.3% in 2022.
- China Pharma Holdings' Exchange Rate Effect stood at $3874.0 in 2022, then soared by 1201.99% to $50439.0 in 2023, then slumped by 225.7% to -$63400.0 in 2024, then surged by 106.08% to $3856.0 in 2025, then plunged by 1189.76% to -$42021.0 in 2026.
- Business Quant data shows CPHI's Exchange Rate Effect at -$42021.0 in Q1 2026, $3856.0 in Q4 2025, and $42392.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -42,021.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,021.00 |
| Mar 31, 2026 | -42,021.00 |
| Dec 31, 2025 | 3,856.00 |
| Dec 31, 2025 | 3,856.00 |
| Sep 30, 2025 | 42,392.00 |
| Sep 30, 2025 | 42,392.00 |
| Jun 30, 2025 | -39,627.00 |
| Jun 30, 2025 | -39,627.00 |
| Mar 31, 2025 | -5,371.00 |
| Mar 31, 2025 | -5,371.00 |
| Dec 31, 2024 | -63,400.00 |
| Dec 31, 2024 | -63,400.00 |
| Sep 30, 2024 | 10,243.00 |
| Sep 30, 2024 | 10,243.00 |
| Jun 30, 2024 | -5,584.00 |
| Jun 30, 2024 | -5,584.00 |
| Mar 31, 2024 | -6,655.00 |
| Mar 31, 2024 | -6,655.00 |
| Dec 31, 2023 | 50,439.00 |
| Dec 31, 2023 | 50,439.00 |